AOA Dx
ActiveBlood Test for Early Detection of Ovarian Cancer
What it does
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Its site says now · captured 2026-08-23
AOA DX – Early cancer detection
The future of early cancer detection is now
Next to it in Healthcare and bio · early cancer diagnostics
- NumenY Combinator S23
Engineering a future without cancer deaths.
- Yemaachi BiotechnologyY Combinator S21
Diversifying precision cancer diagnostics and treatments
- NearWaveY Combinator W22
Helping physicians select the right therapy for breast cancer patients
- DigistainY Combinator S21
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
- Humane GenomicsY Combinator S21
A platform to make artificial viruses as cancer therapeutics.
- TippingPoint BiosciencesSOSV SOSV IndieBio SF 14
First ever therapeutics for cancers driven by aberrant chromatin networks
- Signatur BiosciencesY Combinator S22
Simple tests for complex diseases.
- CrosscopeTechstars TS 2020
Crosscope | Next Generation Pathology